LoadingMAT
Griffith Peter H. reported Grant or award in MATTEL INC /DE/: 58858 units of Restricted Stock Units (derivative), dated 2026-10-20. The full Form 4 contains 2 transaction entries.
DLTR
Mitchell John S. JR reported Tax/exercise withholding in DOLLAR TREE, INC.: 466 units of Common Stock, dated 2026-10-03. The full Form 4 contains 1 transaction entry.
COTY
Strobel Markus reported Grant or award in COTY INC.: 273723 units of Restricted Stock Units (derivative), dated 2026-10-19. The full Form 4 contains 2 transaction entries.
COTY
Blazewicz Kristin reported Exercise or conversion in COTY INC.: 86487 units of Class A common stock, dated 2026-10-19. The full Form 4 contains 6 transaction entries.
PDSB
Dawson John Andrew reported Grant or award in PDS Biotechnology Corp: 22700 units of Stock Option (Right to Buy) (derivative), dated 2026-10-18. The full Form 4 contains 1 transaction entry.
COTY
von Bayern Anna reported Exercise or conversion in COTY INC.: 61050 units of Class A common stock, dated 2026-10-19. The full Form 4 contains 6 transaction entries.
COTY
Zafar Ayesha reported Exercise or conversion in COTY INC.: 27028 units of Class A common stock, dated 2026-10-19. The full Form 4 contains 7 transaction entries.
ADPT
RUBINSTEIN JULIE reported Exercise or conversion in Adaptive Biotechnologies Corp: 11881 units of Common Stock, dated 2026-10-19. The full Form 4 contains 11 transaction entries.
TALO
Control Empresarial de Capitales S.A. de C.V. reported Sale in TALOS ENERGY INC.: 2141590 units of Common Shares (as defined in Exhibit 99.1 hereto), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
AIG
Walsh Keith reported Tax/exercise withholding in AMERICAN INTERNATIONAL GROUP, INC.: 688 units of Common Stock, dated 2026-10-21. The full Form 4 contains 1 transaction entry.
BPRE
KAMFAR RAMIN reported Purchase in Bluerock Private Real Estate Fund: 64662 units of Common Shares of Beneficial Interest, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
SEAT
Donnini David reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
DeFlorio Jane E. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
Dixon Craig A. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
ANDERSON MARK M. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
Boehly Todd L reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
SEAT
Masino Julie D. reported Exercise or conversion in Vivid Seats Inc.: 245 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 2 transaction entries.
PACS
Murray Jason Hulse reported Sale in PACS Group, Inc.: 1620 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
GRCE
Opaleye Management Inc. reported Purchase in Grace Therapeutics, Inc.: 4256 units of Common Stock, par value $0.0001 per share, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
META
Olivan Javier reported Sale in Meta Platforms, Inc.: 946 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 5 transaction entries.
CRSP
Silver Andrew Jacob reported Grant or award in CRISPR Therapeutics AG: 25000 units of Restricted Stock Units (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
PALI
Capers Julien E. reported 787,300 shares of Common Stock in PALISADE BIO, INC. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
IOT
Kirchhoff Benjamin Louis reported Sale in Samsara Inc.: 770 units of Class A Common Stock, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
INV
Stober Eric reported 1,818,182 shares of Common Stock in Innventure, Inc. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
